Physician profile
Bernard Gonik
NPI 1164469680
$140,885.83
in general payments reported to CMS, 2019-2025
12 companies · $18K in 2025
The $18K reported for 2025 was more than what 99% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $4,550 · 2021: $22K · 2022: $3,510 · 2023: $28K · 2024: $50K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Travel and Lodging: $26K · Consulting Fee: $18K · Food and Beverage: $1,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,309.28 |
| Travel and Lodging | $25,570.50 |
| Consulting Fee | $17,962.03 |
| Food and Beverage | $1,736.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67,027.41 | 2019-2025 | |
| Sanofi Pasteur INC. | $52,830.70 | 2019-2024 | |
| Pfizer International LLC | $10,600.00 | 2020-2023 | |
| Biogen, INC. | $3,510.00 | 2022 | |
| Roche Diagnostics International Ltd | $3,180.00 | 2025 | |
| Janssen Research & Development, LLC | $2,381.30 | 2025 | |
| Lupin INC. | $1,124.95 | 2019 | |
| Hologic Sales and Service, LLC | $142.45 | 2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Gynesonics, INC. | $71.59 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $17.43 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Gonik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.